BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results Full Year 2014 Financial Highlights · Net sales increased by $8.7 million, or 16.5%, year over year, from $52.7 million in 2013 to $61.4 million in 2014. · Gross profit grew by approximately 17.9% from $25.7 million in 2013 to $30.3 million in 2014. · Cash and] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): April 15, 2015 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T18:02:25+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

MPEL [Melco Crown Entertainment] 20-F: (Original Filing)

[INTRODUCTION 1 GLOSSARY 5 7 PART I 8 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 8 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 8 ITEM 3. KEY INFORMATION 9 A. SELECTED FINANCIAL DATA 9 B. CAPITALIZATION AND INDEBTEDNESS 12 C. REASONS FOR THE OFFER AND USE OF PROCEEDS 12 D. RISK FACTORS 13 ITEM 4. INFORMATION ON THE] [Execution Version AMENDMENT NO. 3 TO SHAREHOLDERS’ AGREEMENT Amendment No. 3 MCE Cotai New Cotai MCE Company This AMENDMENT NO. 3 TO SHAREHOLDERS’ AGREEMENT ( BACKGROUND (A) Shareholders’ Agreement) (B) ( Original Capital Commitments (C) (Amendment No. 1 (MCE Follow On Commitment (New Cotai Equity Option On 25 September 2012, MCE Cotai, New Cotai, MCE and the Company entered into] [AMENDMENT NO. 4 TO SHAREHOLDERS’ AGREEMENT Amendment No. 4 MCE Cotai New Cotai MCE Company This AMENDMENT NO. 4 TO SHAREHOLDERS’ AGREEMENT ( BACKGROUND (A) Shareholders’ Agreement (B) Phase I Capital Commitments (C) Phase II Preliminary Design Work) On the date of this Amendment No. 4, the Board approved a budget of * for the preliminary development and initial concept] [List of Subsidiaries 1. MCE Finance Limited, incorporated in the Cayman Islands 2. MPEL International Limited, incorporated in the Cayman Islands 3. MPEL Nominee One Limited, incorporated in the Cayman Islands 4. MPEL Nominee Two Limited, incorporated in the Cayman Islands 5. MPEL Investments Limited, incorporated in the Cayman Islands 6. Melco Crown (Macau) Limited, incorporated in the Macau Special] [Certification by the Chief Executive Officer I, Lawrence Yau Lung Ho, certify that: 1. I have reviewed this annual report on Form 20-F of Melco Crown Entertainment Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [Certification by the Chief Financial Officer I, Geoffrey Stuart Davis, certify that: 1. I have reviewed this annual report on Form 20-F of Melco Crown Entertainment Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Executive Officer 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 7 d807931dex131.htm EX-13.1] [Certification by the Chief Financial Officer 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 8 d807931dex132.htm EX-13.2] [Partners: Paul Aherne* Ashley Davies* Tim Haynes*** Fraser Hern* Kristen Kwok* Arwel Lewis* Andy Randall** Denise Wong* 15 April 2015 Our Ref: DW/AH/M4237-H01577 The Board of Directors Melco Crown Entertainment Limited 36th Floor The Centrium 60 Wyndham Street Central Hong Kong Dear Sirs FORM 20-F Commission Exchange Act Yours faithfully WALKERS Walkers Suite 1501-1507, Alexandra House, 18 Chater Road, Central,] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements Nos. 333-185477 and 333-143866 on Form S-8 of our reports dated March 25, 2015, relating to the consolidated financial statements and financial statement schedule of Melco Crown Entertainment Limited and its subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over]

By | 2016-03-30T00:56:40+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments
Read More

ZNH [CHINA SOUTHERN AIRLINES CO] 6-K: (Original Filing)

[By order of the Board China Southern Airlines Company Limited Xie Bing and Liu Wei Joint Company Secretaries Guangzhou, the People’s Republic of China 14 April 2015 As at the date of this announcement, the Directors include Si Xian Min, Yuan Xin An and Yang Li Hua as non-executive Directors, Tan Wan Geng, Zhang Zi Fang and Li Shao Bin] []

By | 2016-03-23T19:42:31+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, ZNH|Tags: , , , , , |0 Comments
Read More

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[Deutsche Bank Trust Company Americas Trust & Securities Services Global Equity Services April 8, 2015 DEPOSITARY RECEIPTS Depositary’s Notice of Annual General Meeting of Shareholders of Melco Crown Entertainment Limited (the “Company”): Issuer: Melco Crown Entertainment Limited / Cusip 585464100 Country: Incorporated in the Cayman Islands Meeting Details: Annual General Meeting of Shareholders of the Company on May 20, 2015] [MELCO CROWN ENTERTAINMENT LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 20, 2015 Dear Shareholders, Company You are cordially invited to attend the Annual General Meeting of Shareholders of Melco Crown Entertainment Limited (the “ 1. 2. To re-elect each of the following directors: (a) Mr. Lawrence Yau Lung Ho as the executive director of] [Annual General Meeting of Shareholders (Name of ADR holder) (Number of ADRs held) Resolutions presented for consideration by the Annual General Meeting of Shareholders of Melco Crown Entertainment Limited (the “Company”) on May 20, 2015. Affirmative Negative Abstained ORDINARY RESOLUTIONS 1) 2) To re-elect each of the following directors:] [Form 6–K TABLE OF CONTENTS Voting Card MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA Chief Financial Officer 3]

By | 2016-03-30T00:59:19+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 10-K: (Original Filing)

[FORM 10-K (Mark One) x December 31, 2014 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2014 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.3 5 ex23-3.htm EX-23.3] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.4 6 ex23-4.htm EX-23.4] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Ronghua Wang Chief Executive Officer EX-32.1 9 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Qinghua Liu Interim Chief Financial Officer EX-32.2 10 ex32-2.htm EX-32.2]

By | 2016-03-28T18:06:05+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] 20-F: (Original Filing)

[WuXi PharmaTech (Cayman) Inc. Page INTRODUCTION 1 2 PART I. ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 27 ITEM 4A. UNRESOLVED STAFF COMMENTS 49 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 49 ITEM 6. DIRECTORS, SENIOR MANAGEMENT] [Execution Version Dated 16 February 2015 WUXI PHARMATECH (CAYMAN) INC. AS BORROWER WUXI APPTEC HOLDING COMPANY, INC. WUXI APPTEC, INC. WUXI APPTEC (BVI) INC. WUXI APPTEC (HONG KONG) LIMITED AS ORIGINAL GUARANTORS CITIGROUP GLOBAL MARKETS ASIA LIMITED AS COORDINATING ARRANGER AND CITICORP INTERNATIONAL LIMITED AS AGENT FACILITY AGREEMENT FOR US$165,000,000 SENIOR TERM AND REVOLVING LOAN FACILITY CONTENTS Clause Page 1.] [LIST OF SUBSIDIARIES Name Abbreviation Place of Incorporation WuXi AppTec (BVI) Inc. WXAT BVI British Virgin Islands WuXi AppTec Co., Ltd. WXAT PRC WuXi AppTec (Shanghai) Co., Ltd. WASH PRC Shanghai SynTheAll Pharmaceutical Co., Ltd. STA PRC WuXi AppTec (Suzhou) Co., Ltd. WASZ PRC WuXi AppTec (Tianjin) Co., Ltd. WATJ PRC WuXi AppTec Holding Company, Inc. AppTec Holding WuXi AppTec,] [Certification by the Chief Executive Officer I, Ge Li, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Certification by the Chief Financial Officer I, Edward Hu, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered] [Section 906 of the Sarbanes-Oxley Act of 2002 Ge Li Chief Executive Officer EX-13.1 6 d796029dex131.htm EX-13.1] [Certification by the Chief Financial Officer Edward Hu Chief Financial Officer EX-13.2 7 d796029dex132.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement No. 333-182917 on Form S-8 of our reports dated April 15, 2015, relating to the consolidated financial statements and financial statement schedule of Wuxi PharmaTech (Cayman) Inc. and its subsidiaries, and the effectiveness of Wuxi PharmaTech (Cayman) Inc. and its subsidiaries’ internal]

By | 2016-03-24T02:47:01+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

TEDU [Tarena International] 20-F: (Original Filing)

[INTRODUCTION 1 2 PART I. 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 39 ITEM 4.A. UNRESOLVED STAFF COMMENTS 68 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 69 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 87 ITEM] [REGISTRATION RIGHTS AGREEMENT Agreement REGISTRATION RIGHTS AGREEMENT (this “ Company (1) Tarena International, Inc., a company incorporated in the Cayman Islands (the “ Investor (2) New Oriental Education & Technology Group Inc., a company incorporated in the Cayman Islands (the “ Party Parties The Investor on the one hand, and the Company on the other hand, are sometimes herein referred] [List of Subsidiaries of Tarena International, Inc. Name Jurisdiction of Incorporation Tarena Hong Kong Limited Hong Kong Wholly-owned subsidiary Tarena Software Technology (Hangzhou) Co., Ltd. PRC Wholly-owned subsidiary Tarena Technologies Inc. PRC Wholly-owned subsidiary Shenyang Tarena Technology Co., Ltd. PRC Wholly-owned subsidiary Jinan Tarena Software Co., Ltd. PRC Wholly-owned subsidiary Qingdao Tarena Software Technology Co., Ltd. PRC Wholly-owned subsidiary Tarena] [I, Shaoyun Han, certify that: 1. I have reviewed this annual report on Form 20-F of Tarena International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Suhai Ji, certify that: 1. I have reviewed this annual report on Form 20-F of Tarena International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification by the Chief Executive Officer Sarbanes-Oxley (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Shaoyun Han Chief Executive Officer 1] [Certification by the Chief Financial Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Suhai Ji Chief Financial Officer 1] [[Conyers Dill & Pearman Letterhead] Tarena International, Inc. Suite 10017, Building E, Zhongkun Plaza, A18 Bei San Huan West Road, Haidian District Beijing 100098 The People’s Republic of China 15 April 2015 Dear Sirs Tarena International, Inc. Annual Report SEC We consent to the reference to our firm under the heading “Item 10.Additional Information—E. Taxation—Cayman Islands Taxation” in Tarena International,] [[Han Kun Law Offices Letterhead] April 15, 2015 Tarena International, Inc. Suite 10017, Building E, Zhongkun Plaza, A18 Bei San Huan West Road, Haidian District Beijing 100098 The People’s Republic of China Dear Sir/Madam: Annual Report SEC We hereby consent to the reference of our name under the heading “Item 3. Key Information—D. Risk Factors—Risks Relating to Our Corporate Structure,”] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statement (No.: 333-197226) on Form S-8 of Tarena International, Inc. of our report dated April 15, 2015, with respect to the consolidated balance sheets of Tarena International, Inc. as of December 31, 2013 and 2014, and the related consolidated statements of comprehensive income,]

By | 2016-03-16T12:01:57+00:00 April 15th, 2015|Categories: Chinese Stocks, SEC Original, TEDU|Tags: , , , , , |0 Comments
Read More

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred Melco Crown Entertainment Limited (Incorporated in the Cayman Islands with limited liability) (SEHK Stock Code: 6883) PROPOSALS FOR (1) RE-ELECTION AND APPOINTMENT OF DIRECTORS, (2) GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, (3) AMENDMENTS TO SHARE] [Form 6–K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED]

By | 2016-03-30T01:01:43+00:00 April 15th, 2015|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments
Read More

HIMX [Himax Technologies] 20-F: (Original Filing)

[TABLE OF CONTENTS Page 4 CERTAIN CONVENTIONS 4 PART I 6 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 6 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6 ITEM 3. KEY INFORMATION 6 3.A. Selected Financial Data 6 3.B. Capitalization and Indebtedness 8 3.C. Reason for the Offer and Use of Proceeds 8 3.D. Risk Factors 9 ITEM 4.] [Himax Technologies, Inc. List of Subsidiaries Subsidiary Jurisdiction of Percentage of Himax Technologies Limited ROC 100.0 % Himax Technologies Korea Ltd. South Korea 100.0 % Himax Semiconductor, Inc. ROC 100.0 % Himax Technologies (Samoa), Inc. Samoa 100.0 (1) % Himax Technologies (Suzhou) Co., Ltd. PRC 100.0 (2) % Himax Technologies (Shenzhen) Co., Ltd. PRC 100.0 (2) % Himax Display, Inc.] [Certification I, Jordan Wu, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification I, Jackie Chang, certify that: 1. I have reviewed this annual report on Form 20-F of Himax Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification April 15, 2015 Jordan Wu, the President and Chief Executive Officer of Himax Technologies, Inc., and Jackie Chang, the Chief Financial Officer of Himax Technologies, Inc., each certifies that, to the best of his or her knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements (No. 333-137585 and No. 333-176863) on Form S-8 and the registration statements (No. 333-188253 and No. 333-189052) on Form F-3 of Himax Technologies, Inc. and subsidiaries of our reports dated April 15, 2015, with respect to the consolidated]

By | 2016-03-15T23:10:12+00:00 April 15th, 2015|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar